Cepheid
Isita Jhulki is a highly experienced Senior Scientist in Analytical Chemistry at Cepheid since September 2023, with previous expertise as a Scientist at Amyris from February 2022 to September 2023, where significant contributions included optimizing metabolic pathways and conducting high-throughput screening for natural product synthesis. Prior roles include postdoctoral researcher at the National Cancer Institute, focusing on RNA-modifying enzymes, and a postdoctoral fellow at Texas A&M University, where research centered on the enzyme-mediated biosynthesis of the antibiotic Roseoflavin. Isita holds a PhD in Chemistry from Texas A&M University, a Master’s degree from the Indian Institute of Technology, and a Bachelor’s degree from Presidency University.
This person is not in any teams
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.